USFDA conducts inspection at Syngene International’s Biologics facility

15 Nov 2022 Evaluate

The US Food and Drug Administration (USFDA) has conducted its pre-approval inspection at Syngene International’s Biologics facility in Bangalore from November 07, 2022 till November 15, 2022. The inspection was completed successfully without 483 observations.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.

Syngene Internation. Share Price

915.70 -0.55 (-0.06%)
28-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 915.70
Sagility India 34.94
AGS Transact Tech 79.93
Just Dial 1119.55
Krystal Integrated 769.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.